milliporesigma videos
-
Meet The Experts: Part 3 - Chemometrics And Model Building
5/1/2023
Watch part 3 of this 4-part interview series to learn about chemometrics and model building from expert Johan Cailletaud.
-
Meet The Experts: Part 1 - Process Analytical Technology (PAT)
5/1/2023
Watch part 1 of this 4-part interview series to learn about process analytical technology (PAT) from expert Stacy Shollenberger.
-
Meet The Experts: PAT, Raman Spectroscopy, And Chemometrics
4/14/2023
Gain a better understanding of process analytical technology (PAT), Raman spectroscopy, chemometrics, and Raman applications in bioprocessing.
-
Targeting The Fast Lane With Optimized Viral Detection
4/6/2023
Discover a groundbreaking method that allows you to accelerate viral detection by combining the broad range of NGS with the sensitivity of PCR.
-
A Dedicated Team To Safely Store Your Cell And Virus Banks
2/27/2023
The safety of your cell and virus banks must be your top priority. Learn about a team dedicated to the safety of your material along with their related services.
-
Storing Your Banks With Ease And Confidence
2/17/2023
Discover a biorepository that will fulfill your need of long-term and short-term storage. You can never be too careful with your cell or virus banks. Explore three global sites that will ensure the safety of your bank.
-
The Journey To Safety Through Viral Clearance
12/1/2022
Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.
-
The ICH Q5A Revision, Its New Scope And Guidance
12/1/2022
Learn about the ICH Q5A revision addressing viral safety of biotechnology products derived from cell lines of human or animal origin that was recently published for public comment.
-
ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients
6/7/2022
The ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients is the most commonly referenced quality guideline in pharmaceutical product and contains five segments. Watch the video to learn more.
-
Combining Expertise With Best-In-Class Technology
10/20/2021
Members of the MilliporeSigma leadership team reflect on the longstanding experience of our BioReliance® viral vector manufacturing facilities. Our legacy experience, alongside our brand new facility and latest industry innovations, ensure we are a preferred partner to pioneer the path to cures.